Iterum Therapeutics Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 44c
May 14, 2020 6:49 AM EDTIterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.90), $0.44 better than the analyst estimate of ($1.34).
"During this challenging time, it is more important than ever to avoid hospitalization. We believe sulopenem, as potentially the first and only oral and IV penem antibiotic, will... More



